Study reveals no impact of age on outcome in chronic myeloid leukemia patients treated with imatinib
Wednesday, March 30, 2011 - 11:31
in Health & Medicine
While the median age at diagnosis for chronic myeloid leukemia (CML) is over 60 years old and incidence increases dramatically with age,limited data are available about the long-term outcome for older patients treated with imatinib, the standard first-line therapy used to treat CML. Results from a study published today in Blood, the Journal of the